CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7 | -97.2% | 4 | -95.5% | 0.00% | – |
Q2 2023 | $252 | +1160.0% | 89 | +2125.0% | 0.00% | – |
Q1 2023 | $20 | -53.5% | 4 | 0.0% | 0.00% | – |
Q4 2022 | $43 | – | 4 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 4 | -91.7% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 48 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 48 | +1100.0% | 0.00% | – |
Q1 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 4 | -95.6% | 0.00% | – |
Q1 2017 | $2,000 | – | 90 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |